We are live on ! Find out more
TRAW icon

Traws Pharma

34 hedge funds and large institutions have $10.5M invested in Traws Pharma in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

342% more capital inflows, than outflows

Capital inflows: $7.3M | Capital outflows: $1.65M

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

36% more funds holding

Funds holding: 25 → 34 (+9)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

3% more ownership

Funds ownership: 10.15% → 13.15% (+3%)

45% less call options, than puts

Call options by funds: $204K | Put options by funds: $368K

Holders
34
Holders Change
+9
Holders Change %
+36%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
8
Reduced
7
Closed
6
Calls
$204​K
Puts
$368​K
Net Calls
-⁠$164​K
Net Calls Change
-⁠$164​K

TRAW Hedge Fund Activity: Q3 2021 in Review

34 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q3 2021, worth a combined $10.5M — down 5.7% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new TRAW positions and 6 closed out — a net gain of 9 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $1.29M. The largest seller was State Street, cutting an estimated $333K.

  • 34 institutional investors held Traws Pharma (TRAW) as of Q3 2021, up from 25 in Q2 2021.
  • Funds reported $10.5M of Traws Pharma stock for Q3 2021, down 5.7% quarter-over-quarter.
  • 15 funds opened new Traws Pharma positions in Q3 2021 and 6 closed out, a net change of +9 holders.
  • The largest Traws Pharma buyer in Q3 2021 was Alyeska Investment Group, an estimated $1.29M added.
  • The largest Traws Pharma seller in Q3 2021 was State Street, an estimated $333K sold.

Based on aggregated 13F filings for Q3 2021.